• CBD Attenuates Orofacial Inflammatory Pain via FAAH Modulati

  2026-05-13

  This study demonstrates that cannabidiol (CBD) robustly alleviates both sensory and emotional aspects of orofacial inflammatory pain in mice, primarily by downregulating FAAH and enhancing endocannabinoid signaling. The findings highlight key mechanistic links between endocannabinoid modulation and comprehensive pain management, with implications for translational research.

• PreScission Protease (PSP): Tag Cleavage for Protein Purific

  2026-05-13

  PreScission Protease (PSP) addresses the need for specific and efficient removal of fusion tags from recombinant proteins, minimizing non-specific cleavage and preserving native protein structure. This tool is suitable for workflows requiring HRV 3C protease specificity and low-temperature activity, but is not intended for applications outside defined sequence recognition or protocols lacking buffer control.

• Amyloid β-Peptide (1-42): Mechanisms and Innovations in AD R

  2026-05-12

  Explore Amyloid β-Peptide (1-42) as a pivotal Alzheimer’s disease research peptide, delving into its mechanistic roles, ion channel modulation, and the latest assay innovations. This article uniquely integrates practical insights with advanced scientific findings to inform rigorous experimental design.

• Lysoptosis: Serpin-Regulated Lysosome-Dependent Cell Death P

  2026-05-12

  The reference study defines 'lysoptosis' as a conserved lysosome-dependent cell death pathway, functionally distinct from other forms of regulated cell death due to its reliance on lysosomal membrane permeabilization and cathepsin activity. Its findings clarify the protective role of intracellular serpins across evolution, with significant implications for mechanistic cell death research and targeted inhibition strategies.

• Sodium Disrupts Mitochondrial Energy to Drive NECSO Cell Dea

  2026-05-11

  Qiao et al. (2025) reveal that sodium influx via TRPM4 channels induces necrosis by disrupting mitochondrial energy metabolism, characterizing a novel necrosis pathway termed NECSO. This work clarifies the mechanistic interplay between ion homeostasis, mitochondrial dysfunction, and cell fate, providing new directions for apoptosis and mitochondrial function analysis.

• Angiotensin I: Translational Leverage in Cardiovascular Rese

  2026-05-11

  Explore the mechanistic foundation and strategic opportunities offered by Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) for advancing translational research in cardiovascular and neuroendocrine systems. This article provides evidence-backed guidance, protocol specifics, and a competitive landscape analysis, with actionable insights for antihypertensive drug screening and renin-angiotensin system modeling. Leveraging APExBIO’s high-purity Angiotensin I, we move beyond standard workflows to chart visionary directions for next-generation experimental design.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:

  2026-05-10

  5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine offers high-purity, DMSO-soluble performance for reliable α2-adrenergic receptor agonist research, empowering studies in immune rejection modulation and post-surgery osteosarcoma recurrence. Learn how novel hydrogel-based protocols and immune pathway insights are driving reproducible, high-impact experiments.

• ISR Inhibition Prevents and Reverses Forgetting in Epilepsy

  2026-05-09

  This study demonstrates that activation of the integrated stress response (ISR) underpins both natural and epilepsy-associated accelerated forgetting in mice. Through targeted ISR inhibition with ISRIB, the authors show that memory loss can be prevented and even reversed, providing mechanistic and translational insights into cognitive decline related to neurological disease.

• Drosophila Keap1 Forms Nuclear Condensates Under Oxidative S

  2026-05-08

  This study reveals that Drosophila Keap1 (dKeap1) assembles into nuclear condensates in response to oxidative stress, a mechanism that involves intrinsically disordered regions and domain-specific regulation. These findings provide new mechanistic insight into Keap1's nuclear functions and its broader roles in oxidative response and developmental gene control.

• Recombinant Human Growth Hormone: Molecular Precision in Cho

  2026-05-08

  Explore the molecular intricacies of Recombinant Human Growth Hormone (GH) in chondrocyte proliferation and differentiation. This article uniquely bridges advanced mechanistic insight with practical assay optimization for research applications.

• Mitofusin 2 Modulates Angiotensin II-Induced Vascular Senesc

  2026-05-07

  This study reveals that Angiotensin II drives endothelial cell senescence by suppressing mitofusin 2 (MFN2), implicating mitochondrial dysfunction in vascular aging. The work uncovers a STAT3-BCL6-MFN2 regulatory axis and highlights MFN2 as a crucial gatekeeper against age-related vascular decline.

• Precision Proteolysis in Condensate Biology: Strategic Advan

  2026-05-07

  This thought-leadership article unpacks the mechanistic and strategic role of PreScission Protease (PSP) in advancing protein purification and condensate research. By weaving together recent findings on Keap1 condensate assembly, quantitative workflow data, and scenario-driven guidance, we provide translational researchers with a roadmap to high-fidelity fusion tag cleavage and robust experimental reproducibility.

• URB597 (KDS-4103): Precision FAAH Inhibition for Translation

  2026-05-06

  Explore how URB597 (KDS-4103) empowers translational researchers to dissect endocannabinoid signaling, bridge mechanistic discoveries to actionable protocols, and advance the field of neuroplasticity and inflammatory pain management beyond conventional product guides. This thought-leadership article contextualizes recent cannabidiol (CBD) pain research, offers protocol guidance, and positions URB597 from APExBIO as a strategic lever for next-generation translational studies.

• Anlotinib Hydrochloride: Data-Driven Solutions for Angiogene

  2026-05-06

  This article delivers evidence-based, scenario-driven guidance for optimizing endothelial cell assays, with a focus on Anlotinib hydrochloride (SKU C8688). Drawing on peer-reviewed data and real laboratory challenges, it demonstrates how this multi-target tyrosine kinase inhibitor enhances reproducibility and reliability in cancer research workflows.

• URB597 (KDS-4103): Optimizing In Vivo FAAH Inhibition Workfl

  2026-05-05

  Harness the precision of URB597 (KDS-4103) to selectively inhibit FAAH and elevate anandamide levels, unlocking robust insights in neuroplasticity and neuroinflammation research. This guide translates breakthrough findings—such as endocannabinoid modulation in pain models—into actionable protocols and troubleshooting strategies, ensuring reproducible results and streamlined assay development.

14431 records 1/963 page Next 12345 下5页 Last page